Mayo Clinic research yields breakthrough in mobile determination of QT prolongation

February 4, 2021

ROCHESTER, Minn. — Researchers from Mayo Clinic and AliveCor Inc. have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. This research has yielded a breakthrough in determining the health of the electrical recharging system in a patient’s heart. The researchers determined that a smartphone-enabled mobile EKG device can rapidly and accurately determine a patient’s QTc, thereby identifying patients at risk of sudden cardiac death from congenital long QT syndrome (LQTS) or drug-induced QT prolongation.

Read the full story here.

– Sudden Cardiac Arrest Foundation

You can save a life …

Make a Donation or Give an AED Today